NEXR
Nexera Technologies Ltd
NASDAQ · Healthcare · Biotechnology · IL
$1.70
−4.49%Margins
Gross margin
7.7%
EBITDA margin
-34.3%
EBIT margin
-40.6%
Net margin
-20.3%
FCF margin
-24.8%
-104.8%
Return on equity
-66.7%
Return on assets
-177.2%
Return on invested capital
1.72x
Asset turnover
-$6.2M
Cash from operations
$1.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026